iotrolan has been researched along with Chronic Disease in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartwig, CH | 1 |
Braunschweig, R | 1 |
Böhm, P | 1 |
Cormann, PL | 1 |
1 other study available for iotrolan and Chronic Disease
Article | Year |
---|---|
[Double-contrast arthro-CT in diagnosis of shoulder instability].
Topics: Adult; Athletic Injuries; Bone Transplantation; Chronic Disease; Contrast Media; Female; Humans; Joi | 1995 |